Moderna surges 10% after Trump says US government reached deal for 100 million doses of its coronavirus vaccine
Advertisement
Carmen Reinicke
Aug 12, 2020, 21:14 IST
Nurse Kath Olmstead, right, gives volunteer Melissa Harting, of Harpersville, N.Y. an injection as the world's biggest study of a possible COVID-19 vaccine, developed by the National Institutes of Health and Moderna Inc., gets underway Monday, July 27, 2020, in Binghamton, N.Y.AP Photo/Hans Pennink
Advertisement
President Donald Trump on Tuesday announced that the US government reached a deal with Moderna for 100 million doses of its coronavirus vaccine candidate.
Shares of Moderna spiked as much as 10% on Wednesday.
The company separately announced the deal is worth $1.53 billion and gives the government the option to purchase up to 400 million additional doses of its coronavirus vaccine candidate.
Shares of Moderna spiked as much as 10% on Wednesday after President Donald Trump said on Tuesday that the US government has reached a deal to purchase 100 million doses of the company's coronavirus vaccine candidate.
Moderna announced separately on Tuesday that the deal is worth $1.53 billion, and that it gives the government the option to purchase up to 400 million additional doses of its coronavirus vaccine candidate, mRNA-1273. The COVID-19 vaccine began late-stage human trials in July.
The US government previously awarded Moderna $955 million for vaccine development — the new round of purchases brings its total investment to $2.48 billion, the company said in a press release.
"We are investing in the development and manufacture of the top six vaccine candidates to ensure rapid delivery," Trump said during a Tuesday press conference at the White House. "The military is ready to go. They're ready to deliver a vaccine to Americans as soon as one is fully approved by the FDA, and we're moving very close to that approval."
The deals are part of the Trump administration's Operation Warp Speed program, which is devoted to accelerating the development, manufacture, and distribution of COVID-19 vaccines.
NewsletterSIMPLY PUT - where we join the dots to inform and inspire you. Sign up for a weekly brief collating many news items into one untangled thought delivered straight to your mailbox.